Overview

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

Status:
RECRUITING
Trial end date:
2025-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess how fast BGM0504 gets into the blood stream and how long it takes the body to remove it in participants with impaired kidney function compared to healthy participants.
Phase:
PHASE1
Details
Lead Sponsor:
BrightGene Bio-Medical Technology Co., Ltd.